nodes	percent_of_prediction	percent_of_DWPC	metapath
Masoprocol—IGF1R—breast cancer	0.28	0.759	CbGaD
Masoprocol—L-DOPA—Melphalan—breast cancer	0.161	1	CrCrCtD
Masoprocol—CYP19A1—Exemestane—breast cancer	0.0989	0.291	CbGbCtD
Masoprocol—CYP19A1—breast cancer	0.0886	0.24	CbGaD
Masoprocol—CYP19A1—Letrozole—breast cancer	0.0841	0.247	CbGbCtD
Masoprocol—CYP19A1—Anastrozole—breast cancer	0.075	0.22	CbGbCtD
Masoprocol—CYP19A1—Raloxifene—breast cancer	0.0379	0.111	CbGbCtD
Masoprocol—CYP19A1—Tamoxifen—breast cancer	0.025	0.0736	CbGbCtD
Masoprocol—CYP19A1—Paclitaxel—breast cancer	0.0195	0.0573	CbGbCtD
Masoprocol—CYP19A1—corpus luteum—breast cancer	0.00608	0.147	CbGeAlD
Masoprocol—LTB4R—nipple—breast cancer	0.00256	0.0617	CbGeAlD
Masoprocol—IGF1R—embryo—breast cancer	0.00174	0.042	CbGeAlD
Masoprocol—LTB4R—skin of body—breast cancer	0.00164	0.0395	CbGeAlD
Masoprocol—IGF1R—Topotecan—Irinotecan—breast cancer	0.00152	0.688	CbGdCrCtD
Masoprocol—CYP2J2—nipple—breast cancer	0.00143	0.0345	CbGeAlD
Masoprocol—IGF1R—epithelium—breast cancer	0.00142	0.0343	CbGeAlD
Masoprocol—LTB4R—pituitary gland—breast cancer	0.0014	0.0337	CbGeAlD
Masoprocol—LTB4R—adipose tissue—breast cancer	0.00139	0.0336	CbGeAlD
Masoprocol—IGF1R—skin of body—breast cancer	0.00135	0.0326	CbGeAlD
Masoprocol—LTB4R—adrenal gland—breast cancer	0.00125	0.0301	CbGeAlD
Masoprocol—LTB4R—bone marrow—breast cancer	0.00121	0.0291	CbGeAlD
Masoprocol—LTB4R—female gonad—breast cancer	0.00116	0.0281	CbGeAlD
Masoprocol—IGF1R—adipose tissue—breast cancer	0.00115	0.0277	CbGeAlD
Masoprocol—LTB4R—endocrine gland—breast cancer	0.00108	0.0261	CbGeAlD
Masoprocol—IGF1R—female reproductive system—breast cancer	0.00106	0.0255	CbGeAlD
Masoprocol—IGF1R—adrenal gland—breast cancer	0.00103	0.0249	CbGeAlD
Masoprocol—IGF1R—female gonad—breast cancer	0.000961	0.0232	CbGeAlD
Masoprocol—CYP2J2—skin of body—breast cancer	0.000917	0.0221	CbGeAlD
Masoprocol—IGF1R—endocrine gland—breast cancer	0.000894	0.0216	CbGeAlD
Masoprocol—CYP2J2—endometrium—breast cancer	0.000864	0.0208	CbGeAlD
Masoprocol—CYP2J2—uterus—breast cancer	0.000797	0.0192	CbGeAlD
Masoprocol—CYP2J2—pituitary gland—breast cancer	0.000782	0.0189	CbGeAlD
Masoprocol—LTB4R—lymph node—breast cancer	0.000749	0.0181	CbGeAlD
Masoprocol—CYP2J2—female reproductive system—breast cancer	0.000716	0.0173	CbGeAlD
Masoprocol—IGF1R—lymph node—breast cancer	0.000618	0.0149	CbGeAlD
Masoprocol—ALOX5—adipose tissue—breast cancer	0.000614	0.0148	CbGeAlD
Masoprocol—CYP2J2—endocrine gland—breast cancer	0.000606	0.0146	CbGeAlD
Masoprocol—ALOX5—female reproductive system—breast cancer	0.000564	0.0136	CbGeAlD
Masoprocol—ALOX5—adrenal gland—breast cancer	0.000551	0.0133	CbGeAlD
Masoprocol—ALOX5—bone marrow—breast cancer	0.000533	0.0128	CbGeAlD
Masoprocol—ALOX5—female gonad—breast cancer	0.000513	0.0124	CbGeAlD
Masoprocol—ALOX5—endocrine gland—breast cancer	0.000477	0.0115	CbGeAlD
Masoprocol—CYP19A1—endometrium—breast cancer	0.000471	0.0114	CbGeAlD
Masoprocol—Dobutamine—COMT—breast cancer	0.000449	0.477	CrCbGaD
Masoprocol—CYP19A1—uterus—breast cancer	0.000434	0.0105	CbGeAlD
Masoprocol—CYP19A1—adipose tissue—breast cancer	0.000424	0.0102	CbGeAlD
Masoprocol—CYP19A1—female reproductive system—breast cancer	0.00039	0.00941	CbGeAlD
Masoprocol—CYP19A1—adrenal gland—breast cancer	0.000381	0.00918	CbGeAlD
Masoprocol—IGF1R—Idarubicin—Epirubicin—breast cancer	0.000357	0.162	CbGdCrCtD
Masoprocol—CYP19A1—female gonad—breast cancer	0.000355	0.00856	CbGeAlD
Masoprocol—IGF1R—Idarubicin—Doxorubicin—breast cancer	0.000331	0.15	CbGdCrCtD
Masoprocol—CYP19A1—endocrine gland—breast cancer	0.00033	0.00796	CbGeAlD
Masoprocol—ALOX5—lymph node—breast cancer	0.00033	0.00796	CbGeAlD
Masoprocol—CYP19A1—lymph node—breast cancer	0.000228	0.0055	CbGeAlD
Masoprocol—Dopamine—COMT—breast cancer	0.000219	0.233	CrCbGaD
Masoprocol—Isoprenaline—CYP1A1—breast cancer	0.000117	0.124	CrCbGaD
Masoprocol—L-DOPA—CYP2D6—breast cancer	8.06e-05	0.0857	CrCbGaD
Masoprocol—Dopamine—CYP2D6—breast cancer	7.49e-05	0.0796	CrCbGaD
Masoprocol—ALOX5—Metabolism—CYP3A4—breast cancer	9.87e-06	0.000116	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—HIF1A—breast cancer	9.83e-06	0.000115	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	9.82e-06	0.000115	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—CSF2—breast cancer	9.8e-06	0.000115	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—FGF1—breast cancer	9.8e-06	0.000115	CbGpPWpGaD
Masoprocol—CYP19A1—Integrated Breast Cancer Pathway—KRAS—breast cancer	9.79e-06	0.000115	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—NRG1—breast cancer	9.73e-06	0.000114	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—CYP1B1—breast cancer	9.7e-06	0.000114	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—H2AFX—breast cancer	9.66e-06	0.000113	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism of lipids and lipoproteins—PTEN—breast cancer	9.61e-06	0.000113	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—E2F1—breast cancer	9.59e-06	0.000112	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—LEP—breast cancer	9.59e-06	0.000112	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—GSTA3—breast cancer	9.52e-06	0.000111	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—HSP90AA1—breast cancer	9.52e-06	0.000111	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—COMT—breast cancer	9.52e-06	0.000111	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—HMMR—breast cancer	9.52e-06	0.000111	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—ABCC1—breast cancer	9.52e-06	0.000111	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—CAV1—breast cancer	9.51e-06	0.000111	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—GSTP1—breast cancer	9.47e-06	0.000111	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—KDR—breast cancer	9.4e-06	0.00011	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—HMOX1—breast cancer	9.34e-06	0.000109	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—ITPR1—breast cancer	9.32e-06	0.000109	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—NCOA1—breast cancer	9.26e-06	0.000108	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—SPP1—breast cancer	9.22e-06	0.000108	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—PPARGC1B—breast cancer	9.22e-06	0.000108	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—ESR1—breast cancer	9.16e-06	0.000107	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—STK11—breast cancer	9.12e-06	0.000107	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—CYP19A1—breast cancer	9.12e-06	0.000107	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—ERBB3—breast cancer	9.12e-06	0.000107	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—FGFR2—breast cancer	9.1e-06	0.000107	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—FN1—breast cancer	9.05e-06	0.000106	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—NCOR1—breast cancer	8.97e-06	0.000105	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—PLA2G4A—breast cancer	8.97e-06	0.000105	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—ABCB1—breast cancer	8.97e-06	0.000105	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—NFKBIA—breast cancer	8.94e-06	0.000105	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—NOTCH1—breast cancer	8.85e-06	0.000104	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—TYMS—breast cancer	8.8e-06	0.000103	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—TERT—breast cancer	8.74e-06	0.000102	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—GSTA4—breast cancer	8.7e-06	0.000102	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—CA9—breast cancer	8.7e-06	0.000102	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—PLA2G4A—breast cancer	8.7e-06	0.000102	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—NCOR1—breast cancer	8.7e-06	0.000102	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—GSTM1—breast cancer	8.7e-06	0.000102	CbGpPWpGaD
Masoprocol—CYP19A1—Integrated Breast Cancer Pathway—TP53—breast cancer	8.7e-06	0.000102	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—PIK3CG—breast cancer	8.66e-06	0.000101	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—APC—breast cancer	8.66e-06	0.000101	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—KIT—breast cancer	8.66e-06	0.000101	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—GPX1—breast cancer	8.59e-06	0.000101	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism of lipids and lipoproteins—PTEN—breast cancer	8.56e-06	0.0001	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—EGF—breast cancer	8.56e-06	0.0001	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—CYP1A1—breast cancer	8.51e-06	9.96e-05	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—FGFR1—breast cancer	8.48e-06	9.94e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—GSTA2—breast cancer	8.48e-06	9.93e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—GPX2—breast cancer	8.48e-06	9.93e-05	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—COMT—breast cancer	8.48e-06	9.93e-05	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—GSTP1—breast cancer	8.44e-06	9.89e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—GPX4—breast cancer	8.38e-06	9.81e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—SULT1A1—breast cancer	8.38e-06	9.81e-05	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—HIF1A—breast cancer	8.36e-06	9.79e-05	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—GPX1—breast cancer	8.33e-06	9.76e-05	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—HMOX1—breast cancer	8.33e-06	9.75e-05	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—ITPR1—breast cancer	8.31e-06	9.73e-05	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—MAPK3—breast cancer	8.29e-06	9.71e-05	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—CYP1A1—breast cancer	8.25e-06	9.66e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—GSTA1—breast cancer	8.18e-06	9.58e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—IDH1—breast cancer	8.18e-06	9.58e-05	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—ERCC2—breast cancer	8.18e-06	9.58e-05	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—LEP—breast cancer	8.16e-06	9.55e-05	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—BRAF—breast cancer	8.14e-06	9.53e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—NAT2—breast cancer	8.09e-06	9.48e-05	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—CAV1—breast cancer	8.08e-06	9.47e-05	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—KDR—breast cancer	7.99e-06	9.36e-05	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—ABCB1—breast cancer	7.99e-06	9.36e-05	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—IGF1—breast cancer	7.93e-06	9.28e-05	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—AKT2—breast cancer	7.92e-06	9.28e-05	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—EGFR—breast cancer	7.89e-06	9.24e-05	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—TYMS—breast cancer	7.85e-06	9.19e-05	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—ESR1—breast cancer	7.79e-06	9.12e-05	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—GSTM1—breast cancer	7.76e-06	9.09e-05	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—PLA2G4A—breast cancer	7.76e-06	9.09e-05	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—NCOR1—breast cancer	7.76e-06	9.09e-05	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—FN1—breast cancer	7.69e-06	9.01e-05	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—MTHFR—breast cancer	7.69e-06	9.01e-05	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—PIK3CD—breast cancer	7.61e-06	8.91e-05	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—NFKBIA—breast cancer	7.6e-06	8.9e-05	CbGpPWpGaD
Masoprocol—LTB4R—GPCR downstream signaling—PIK3CA—breast cancer	7.54e-06	8.83e-05	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—NOTCH1—breast cancer	7.53e-06	8.82e-05	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—SERPINE1—breast cancer	7.53e-06	8.82e-05	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—KRAS—breast cancer	7.45e-06	8.73e-05	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—GPX1—breast cancer	7.43e-06	8.7e-05	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—KIT—breast cancer	7.36e-06	8.62e-05	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—APC—breast cancer	7.36e-06	8.62e-05	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—PIK3CG—breast cancer	7.36e-06	8.62e-05	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—CYP1A1—breast cancer	7.35e-06	8.61e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Integrated Breast Cancer Pathway—AKT1—breast cancer	7.35e-06	8.61e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—CAV1—breast cancer	7.31e-06	8.57e-05	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—ERCC2—breast cancer	7.29e-06	8.54e-05	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—EGF—breast cancer	7.28e-06	8.52e-05	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—NOS3—breast cancer	7.19e-06	8.42e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—MED12—breast cancer	7.09e-06	8.31e-05	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—CAV1—breast cancer	7.09e-06	8.31e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—DPYD—breast cancer	7.09e-06	8.31e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—ALDOA—breast cancer	6.98e-06	8.18e-05	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—BRAF—breast cancer	6.92e-06	8.1e-05	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—MTHFR—breast cancer	6.86e-06	8.03e-05	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—PIK3CA—breast cancer	6.85e-06	8.02e-05	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—MDM2—breast cancer	6.82e-06	7.99e-05	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—RAF1—breast cancer	6.8e-06	7.96e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—NCOA3—breast cancer	6.78e-06	7.94e-05	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	6.78e-06	7.94e-05	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—RELA—breast cancer	6.77e-06	7.92e-05	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—IGF1—breast cancer	6.74e-06	7.89e-05	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—AKT2—breast cancer	6.74e-06	7.89e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—SLC2A2—breast cancer	6.73e-06	7.89e-05	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—ERBB2—breast cancer	6.72e-06	7.87e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	6.66e-06	7.8e-05	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—MTOR—breast cancer	6.63e-06	7.77e-05	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—PIK3CB—breast cancer	6.63e-06	7.77e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—ABCG2—breast cancer	6.6e-06	7.72e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—CPT1A—breast cancer	6.6e-06	7.72e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—MTR—breast cancer	6.6e-06	7.72e-05	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—PIK3CD—breast cancer	6.47e-06	7.58e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—HPGDS—breast cancer	6.47e-06	7.58e-05	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—PIK3CG—breast cancer	6.46e-06	7.57e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—HBA1—breast cancer	6.43e-06	7.53e-05	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—SERPINE1—breast cancer	6.4e-06	7.5e-05	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—CXCL8—breast cancer	6.38e-06	7.47e-05	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—HRAS—breast cancer	6.33e-06	7.42e-05	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—CAV1—breast cancer	6.32e-06	7.41e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—GSTT1—breast cancer	6.27e-06	7.35e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—ACHE—breast cancer	6.27e-06	7.35e-05	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—CDKN1B—breast cancer	6.23e-06	7.29e-05	CbGpPWpGaD
Masoprocol—LTB4R—GPCR downstream signaling—AKT1—breast cancer	6.16e-06	7.21e-05	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—NOS3—breast cancer	6.11e-06	7.16e-05	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—CASP3—breast cancer	6.1e-06	7.15e-05	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—IL2—breast cancer	6.09e-06	7.14e-05	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—IL6—breast cancer	6.06e-06	7.1e-05	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	6.04e-06	7.08e-05	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—CCND1—breast cancer	5.94e-06	6.96e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—CYP17A1—breast cancer	5.94e-06	6.96e-05	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—JUN—breast cancer	5.93e-06	6.94e-05	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—CTNNB1—breast cancer	5.88e-06	6.89e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—ENO1—breast cancer	5.88e-06	6.89e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—PTGS1—breast cancer	5.88e-06	6.89e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	5.86e-06	6.86e-05	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—MDM2—breast cancer	5.8e-06	6.79e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—ALB—breast cancer	5.78e-06	6.77e-05	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—RAF1—breast cancer	5.78e-06	6.77e-05	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—MMP9—breast cancer	5.77e-06	6.75e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—CYP2D6—breast cancer	5.77e-06	6.75e-05	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—PIK3CG—breast cancer	5.76e-06	6.75e-05	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—RELA—breast cancer	5.75e-06	6.74e-05	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—CDKN1A—breast cancer	5.75e-06	6.73e-05	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—PTEN—breast cancer	5.73e-06	6.71e-05	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—ERBB2—breast cancer	5.72e-06	6.7e-05	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—PIK3CD—breast cancer	5.68e-06	6.65e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—NCOA2—breast cancer	5.66e-06	6.63e-05	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—MTOR—breast cancer	5.64e-06	6.61e-05	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—PIK3CB—breast cancer	5.64e-06	6.61e-05	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—MAPK8—breast cancer	5.61e-06	6.57e-05	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—ALB—breast cancer	5.61e-06	6.57e-05	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—AKT1—breast cancer	5.59e-06	6.55e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—FASN—breast cancer	5.49e-06	6.43e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—BCHE—breast cancer	5.47e-06	6.4e-05	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—CXCL8—breast cancer	5.42e-06	6.35e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—SLC5A5—breast cancer	5.4e-06	6.32e-05	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—NOS3—breast cancer	5.36e-06	6.28e-05	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—SRC—breast cancer	5.32e-06	6.23e-05	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—CDKN1B—breast cancer	5.29e-06	6.2e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—NQO1—breast cancer	5.21e-06	6.11e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—SLC2A1—breast cancer	5.21e-06	6.11e-05	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—CASP3—breast cancer	5.19e-06	6.08e-05	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—IL2—breast cancer	5.18e-06	6.07e-05	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—VEGFA—breast cancer	5.18e-06	6.06e-05	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—STAT3—breast cancer	5.13e-06	6.01e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	5.11e-06	5.98e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—CYP3A4—breast cancer	5.08e-06	5.95e-05	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—PIK3CD—breast cancer	5.06e-06	5.93e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	5.06e-06	5.92e-05	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—CCND1—breast cancer	5.05e-06	5.92e-05	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—JUN—breast cancer	5.04e-06	5.9e-05	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—CTNNB1—breast cancer	5e-06	5.86e-05	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—ALB—breast cancer	5e-06	5.85e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—CYP1B1—breast cancer	5e-06	5.85e-05	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—PIK3CB—breast cancer	4.95e-06	5.8e-05	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—PTGS2—breast cancer	4.91e-06	5.75e-05	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—MMP9—breast cancer	4.9e-06	5.74e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—HSP90AA1—breast cancer	4.9e-06	5.74e-05	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—MAPK3—breast cancer	4.9e-06	5.74e-05	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—CDKN1A—breast cancer	4.89e-06	5.72e-05	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—PTEN—breast cancer	4.87e-06	5.71e-05	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—NOS3—breast cancer	4.78e-06	5.6e-05	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—MAPK8—breast cancer	4.77e-06	5.59e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—NCOA1—breast cancer	4.77e-06	5.58e-05	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—MYC—breast cancer	4.76e-06	5.58e-05	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—TGFB1—breast cancer	4.75e-06	5.57e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—STK11—breast cancer	4.7e-06	5.5e-05	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—EGFR—breast cancer	4.66e-06	5.46e-05	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—SRC—breast cancer	4.52e-06	5.29e-05	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—PIK3CB—breast cancer	4.41e-06	5.17e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—PTEN—breast cancer	4.41e-06	5.17e-05	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—VEGFA—breast cancer	4.4e-06	5.16e-05	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—KRAS—breast cancer	4.4e-06	5.16e-05	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—PTGS2—breast cancer	4.37e-06	5.12e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—COMT—breast cancer	4.37e-06	5.12e-05	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—STAT3—breast cancer	4.36e-06	5.11e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—GSTP1—breast cancer	4.35e-06	5.09e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—HMOX1—breast cancer	4.29e-06	5.02e-05	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—PTEN—breast cancer	4.28e-06	5.01e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—ITPR1—breast cancer	4.28e-06	5.01e-05	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—MAPK3—breast cancer	4.17e-06	4.88e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—ABCB1—breast cancer	4.12e-06	4.82e-05	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—MYC—breast cancer	4.05e-06	4.74e-05	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—PIK3CA—breast cancer	4.04e-06	4.74e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—TYMS—breast cancer	4.04e-06	4.73e-05	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—TGFB1—breast cancer	4.04e-06	4.73e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—PLA2G4A—breast cancer	4e-06	4.68e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—NCOR1—breast cancer	4e-06	4.68e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—GSTM1—breast cancer	4e-06	4.68e-05	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—EGFR—breast cancer	3.96e-06	4.64e-05	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—TP53—breast cancer	3.91e-06	4.58e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—GPX1—breast cancer	3.83e-06	4.48e-05	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—PTEN—breast cancer	3.81e-06	4.47e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—CYP1A1—breast cancer	3.79e-06	4.44e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—ERCC2—breast cancer	3.76e-06	4.4e-05	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—KRAS—breast cancer	3.74e-06	4.38e-05	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—HRAS—breast cancer	3.74e-06	4.38e-05	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—IL6—breast cancer	3.58e-06	4.19e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—MTHFR—breast cancer	3.53e-06	4.14e-05	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—PIK3CA—breast cancer	3.44e-06	4.03e-05	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—TP53—breast cancer	3.33e-06	3.9e-05	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—AKT1—breast cancer	3.3e-06	3.87e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—CAV1—breast cancer	3.26e-06	3.82e-05	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—HRAS—breast cancer	3.18e-06	3.73e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	3.11e-06	3.65e-05	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—IL6—breast cancer	3.05e-06	3.57e-05	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—PIK3CA—breast cancer	3.02e-06	3.54e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—PIK3CG—breast cancer	2.97e-06	3.48e-05	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—AKT1—breast cancer	2.81e-06	3.29e-05	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—PIK3CA—breast cancer	2.69e-06	3.15e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—PIK3CD—breast cancer	2.61e-06	3.06e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—ALB—breast cancer	2.58e-06	3.02e-05	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—AKT1—breast cancer	2.47e-06	2.89e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—NOS3—breast cancer	2.46e-06	2.88e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—PIK3CB—breast cancer	2.27e-06	2.66e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—PTGS2—breast cancer	2.25e-06	2.64e-05	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—AKT1—breast cancer	2.2e-06	2.57e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—PTEN—breast cancer	1.96e-06	2.3e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—PIK3CA—breast cancer	1.39e-06	1.62e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—AKT1—breast cancer	1.13e-06	1.33e-05	CbGpPWpGaD
